Stephane Bancel serves as Executive at BG Medicine, Inc., where they oversee executive responsibilities. Since joining the company, Stephane Bancel has executed 1571 insider transactions totaling $1.2B, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 8, 2023 involved selling 2,848 shares valued at $480.3K.
Stephane Bancel currently holds 6,181,970 shares of BG Medicine, Inc. (BGMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephane Bancel has been a net seller of BGMD stock. They have purchased $226.2K and sold $1.2B worth of shares.
Stephane Bancel's most recent insider trade was on Feb 8, 2023, when they sold 2,848 shares at $168.64 per share.
Get notified when new Form 4 filings are submitted
| $168.01 |
| Discretionary |
| Feb 8, 2023 | MRNA | $756.5K | Sale | 4,543 | $166.51 | Discretionary |
| Feb 8, 2023 | MRNA | $3.3M | Sale | 19,648 | $165.77 | Discretionary |
| Feb 8, 2023 | MRNA | $1.6M | Sale | 9,589 | $164.65 | Discretionary |
| Feb 8, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Discretionary |
| Feb 2, 2023 | MRNA | $1.5M | Sale | 8,908 | $173.19 | Discretionary |
| Feb 2, 2023 | MRNA | $273.4K | Sale | 1,589 | $172.04 | Discretionary |
| Feb 2, 2023 | MRNA | $342.4K | Sale | 2,001 | $171.11 | Discretionary |
| Feb 2, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Discretionary |
| Feb 2, 2023 | MRNA | $254.7K | Sale | 1,449 | $175.79 | Discretionary |
| Feb 2, 2023 | MRNA | $1.8M | Sale | 10,263 | $174.25 | Discretionary |
| Feb 2, 2023 | MRNA | $2.8M | Sale | 15,790 | $175.03 | Discretionary |
| Feb 1, 2023 | MRNA | $821.1K | Sale | 4,697 | $174.82 | Discretionary |
| Feb 1, 2023 | MRNA | $436.0K | Sale | 2,503 | $174.21 | Discretionary |
| Feb 1, 2023 | MRNA | $103.1K | Sale | 600 | $171.89 | Discretionary |
| Feb 1, 2023 | MRNA | $278.0K | Sale | 1,629 | $170.67 | Discretionary |
| Feb 1, 2023 | MRNA | $1.0M | Sale | 6,024 | $169.85 | Discretionary |
| Feb 1, 2023 | MRNA | $2.8M | Sale | 16,742 | $168.75 | Discretionary |
| Feb 1, 2023 | MRNA | $982.3K | Sale | 5,848 | $167.97 | Discretionary |
| Feb 1, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Discretionary |
| Feb 1, 2023 | MRNA | $338.6K | Sale | 1,957 | $173.03 | Discretionary |
| Jan 26, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Discretionary |
| Jan 26, 2023 | MRNA | $807.8K | Sale | 4,295 | $188.09 | Discretionary |
| Jan 26, 2023 | MRNA | $754.5K | Sale | 3,911 | $192.92 | Discretionary |
| Jan 26, 2023 | MRNA | $632.0K | Sale | 3,289 | $192.16 | Discretionary |
| Jan 26, 2023 | MRNA | $3.0M | Sale | 15,847 | $191.08 | Discretionary |
| Jan 26, 2023 | MRNA | $1.7M | Sale | 8,823 | $190.27 | Discretionary |
| Jan 26, 2023 | MRNA | $725.6K | Sale | 3,835 | $189.21 | Discretionary |
| Jan 25, 2023 | MRNA | $1.4M | Sale | 7,100 | $193.39 | Discretionary |